Allianz Asset Management Gmb H Verastem, Inc. Transaction History

Allianz Asset Management Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$2.79 - $4.09 $870,996 - $1.28 Million	-312,185 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.23 - $7.01 $9,993 - $21,688	3,094 Added 1.0%	312,185 $1.05 Million
Q3 2018 Nov 13, 2018	BUY	$6.86 - $9.97 $458,982 - $667,062	66,907 Added 27.63%	309,091 $2.24 Million
Q2 2018 Aug 13, 2018	BUY	$2.88 - $8.67 $697,489 - $2.1 Million	242,184 New	242,184 $1.67 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.37B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.